Covaxin: WHO approves Bharat Biotech's Covid vaccine for emergency use listing

Covaxin has demonstrated 77.8% effectiveness against symptomatic Covid-19 and 65.2% protection against the Delta variant

Related Keywords

,Covaxin ,Covaxin Who Approval ,Covaxin Who Emergency Use Listing ,Who Covaxin ,Who Covaxin Appproval ,Covaxim Eul Who ,World Health Organization ,World Health Organization Covaxin ,Who Covaxin News ,Covaxin Latest News ,Covaxin Latest Updates ,